Clinical Trial Update: S-100B and Neuron-specific Enolase (NSE) in Spinal Trauma

View source ↗

Summary

The clinical trial evaluating S-100B and neuron-specific enolase as biomarkers in spinal cord injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Snippet

Sponsor: Medical University of Vienna | Conditions: Spinal Cord Injury | Status: COMPLETED